- Home
- NIVF vs XXII Comparison
NIVF vs XXII Comparison
Compare NIVF & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIVF
- XXII
- Stock Information
- Founded
- NIVF 2011
- XXII 1998
- Country
- NIVF Hong Kong
- XXII United States
- Employees
- NIVF N/A
- XXII N/A
- Industry
- NIVF
- XXII Medicinal Chemicals and Botanical Products
- Sector
- NIVF
- XXII Health Care
- Exchange
- NIVF NYSE
- XXII Nasdaq
- Market Cap
- NIVF 2.1M
- XXII 2.1M
- IPO Year
- NIVF N/A
- XXII N/A
- Fundamental
- Price
- NIVF $2.95
- XXII $1.08
- Analyst Decision
- NIVF
- XXII
- Analyst Count
- NIVF 0
- XXII 0
- Target Price
- NIVF N/A
- XXII N/A
- AVG Volume (30 Days)
- NIVF 509.7K
- XXII 603.9K
- Earning Date
- NIVF 01-01-0001
- XXII 05-13-2025
- Dividend Yield
- NIVF N/A
- XXII N/A
- EPS Growth
- NIVF N/A
- XXII N/A
- EPS
- NIVF N/A
- XXII N/A
- Revenue
- NIVF $5,433,375.00
- XXII $23,869,000.00
- Revenue This Year
- NIVF N/A
- XXII $19.23
- Revenue Next Year
- NIVF N/A
- XXII $81.05
- P/E Ratio
- NIVF N/A
- XXII N/A
- Revenue Growth
- NIVF 5.79
- XXII N/A
- 52 Week Low
- NIVF $1.09
- XXII $0.70
- 52 Week High
- NIVF $32.80
- XXII $226.80
- Technical
- Relative Strength Index (RSI)
- NIVF 37.46
- XXII 47.15
- Support Level
- NIVF $2.80
- XXII $1.06
- Resistance Level
- NIVF $3.77
- XXII $1.26
- Average True Range (ATR)
- NIVF 0.74
- XXII 0.17
- MACD
- NIVF 0.22
- XXII 0.04
- Stochastic Oscillator
- NIVF 15.55
- XXII 49.25
About NIVF NEWGENIVF GROUP LIMITED
NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.